Pure Global AI
NCT06337591Completed

Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location

Istituto Nazionale di Ricovero e Cura per AnzianiClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Bladder Cancer
Drug/Device/Intervention
VI-RADS
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Istituto Nazionale di Ricovero e Cura per Anziani
Location
Ancona,Ancona,Jesi, Italy
Timeline & enrollment
Phase
N/A
Start date
Oct 15, 2022
End date
Mar 10, 2024
Enrollment
20 participants
Primary outcome

Sensitivity of Vescical Imaging-Reporting and Data System (VI-RADS) in predicting muscle-invasive bladder cancer after transurethral resection

Summary

VI-RADS was an observational, prospective, multicenter, no profit study. The aim of the study
 was to clarify the clinical validity of the Vesical Imaging-Reporting and Data System
 (VI-RADS) for the assessment of muscle invasion (MI) status in comparison with transurethral
 resection of bladder cancer (TURB) and to evaluate the diagnostic accuracy of the score
 according to the specific tumour location.

ICD-10 classifications
Malignant neoplasm of bladderMalignant neoplasm: Bladder, unspecifiedMalignant neoplasm: Dome of bladderMalignant neoplasm: Overlapping lesion of bladderMalignant neoplasm: Lateral wall of bladder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06337591
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06337591 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Nazionale di Ricovero e Cura per Anziani and is currently Completed. The study focuses on Bladder Cancer. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.